Allarity Therapeutics, Inc. Allarity Therapeutics is now poised to run its DRP® testing in-house in a CLIA-certified ...
Can higher ethanol blends really make your car or bike faster? While racing engines benefit from ethanol's unique properties, does E20 or E85 deliver any real performance gains in our everyday ...
Infections caused by the most dangerous class of drug-resistant bacteria in the United States surged 69% between 2019 and 2023, and one strain carrying the NDM enzyme rose 461% over the same period.
A space thruster using superconducting magnets completed its first orbital tests and could someday propel spacecraft using ...
New data from Ramp and Revelio show that intensive Gen AI adoption is linked to higher headcount and more entry-level hiring, challenging fears that “AI kills jobs” and reshaping IT leaders’ ...
OpenAI's GPT-5.6 Sol advanced another step toward general availability on July 6 when an OpenAI Codex engineer publicly confirmed that Sol Ultra — the model's highest-compute tier — would ship inside ...
Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately ...
Affinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced ...
Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) ...
Not every lightweight laptop deserves a place in your backpack. These Prime Day picks balance battery life, performance, ...
Welcome to the world inside the medical laboratory, a world where medical laboratory scientists and other laboratory professionals find answers to these questions and much more. This is the only ...
Ten years after its launch, Vision 2030 remains Saudi Arabia's roadmap for resilience. The Iran war reinforced—not ...